| Literature DB >> 32420285 |
Kitae E Park1, Omar Allam1, Ludmila Chandler1, Mohammad Ali Mozzafari1, Catherine Ly1, Xiaona Lu1, John A Persing1.
Abstract
Lymphedema may be characterized by a progressive clinical course and limitations in improvement despite multi-modality treatment. In westernized countries, it most commonly presents as an undesirable complication of cancer treatment, particularly breast cancer. In the past several decades, surgical treatments for lymphedema have advanced, alongside developments in microsurgery. Lymphovenous anastomosis (LVA) and lymph node transplantation are physiological therapies that may reduce lymphedema through addressing its route cause. Ablative techniques such as liposuction and subcutaneous excision aid in resolving the accumulation of proteinaceous adipose and fibrotic tissue seen in advanced lymphedema. The goal of this review is to examine the outcomes and limitations of current surgical techniques used in lymphedema management. 2020 Gland Surgery. All rights reserved.Entities:
Keywords: Lymphedema; liposuction; lymph node transfer; lymphovenous anastomosis (LVA)
Year: 2020 PMID: 32420285 PMCID: PMC7225501 DOI: 10.21037/gs.2020.03.14
Source DB: PubMed Journal: Gland Surg ISSN: 2227-684X